Table 2 Clinical outcomes according to APPS gradea
APPS Gr 1 (n = 11) | APPS Gr 2 (n = 88) | APPS Gr 3 (n = 17) | p for trend | |
|---|---|---|---|---|
MV duration, median (IQR), days | 10 (3–23) | 10 (5–21) | 12 (6–21) | 0.721 |
Extubation, N(%) | 7 (63.6) | 33 (37.5) | 3 (17.6) | 0.015 |
Tracheostomy, N(%) | 2 (18.2) | 21 (23.9) | 4 (23.5) | 0.787 |
Hospital length of stay, median (IQR), days | 27 (17–73) | 27 (15–52) | 21 (13–51) | 0.694 |
ICU length of stay, median (IQR), days | 11 (3–23) | 12 (6–22) | 13 (8–21) | 0.702 |
In-hospital mortality, N(%) | 3 (27.3) | 65 (73.9) | 16 (94.1) | < 0.001 |
In-ICU mortality, N(%) | 3 (27.3) | 47 (53.4) | 12 (70.6) | 0.028 |
Use of adjuvant therapy, N(%) | ||||
Inotropics | 9 (81.8) | 79 (89.8) | 15 (88.2) | 0.687 |
Corticosteroid | 10 (90.9) | 81 (92.0) | 17 (100) | 0.291 |
Nitric oxide | 4 (36.4) | 42 (47.7) | 13 (76.5) | 0.024 |
Prone position | 2 (18.2) | 15 (17.0) | 1 (5.9) | 0.313 |
CRRT | 2 (18.2) | 32 (36.4) | 4 (23.5) | 0.989 |
ECMO | 1 (9.1) | 6 (6.8) | 1 (5.9) | 0.757 |